The pill ups early breast cancer risk slightly

	Tweet

Oral contraceptive (OC) use is a risk factor for premenopausal breast cancer, according to pooled data published in the journal Mayo Clinic Proceedings.

However, even for women most at risk—parous women (i.e., those who have given birth) and who used OCs for at least 4 years before their first full-term pregnancy—“the absolute risk ...is very small,” Dr. James R. Cerhan, from Mayo Clinic College of Medicine in Rochester, Minnesota, emphasizes in an accompanying editorial.

Lead author Dr. Chris Kahlenborn, from Altoona Hospital in Pennsylvania, and associates note in their paper that the rate of breast cancer among premenopausal women in the US has increased considerably over the last few decades.

Kahlenborn’s group pooled data from 34 case-control studies of breast cancer and OC use, published since 1980, in which subjects were younger than 50 years old or premenopausal.

Overall, OC use was associated with a slight increase in breast cancer risk (odds ratio, 1.19). For nulliparous women (i.e., those who have never given birth) and who ever used OCs and nulliparous women who used OCs for at least 4 years, corresponding ORs were 1.24 and 1.29.

Among parous women, the OR for ever use was 1.29, while the OR for OC use before a first full-term pregnancy was 1.44, higher than if OCs were used only after the first pregnancy (1.15).

While more studies are needed, the team concludes that OCs are carcinogenic. Their conclusion is bolstered by the recent classification of OCs by the World Health Organization as a group 1 carcinogen.

In a Mayo Clinic press release, Kahlenborn advises doctors to provide more detailed information to women about OCs, calling it a “clear-cut informed-consent issue.”

In his editorial, Cerhan remarks that the increased risk associated with OC use decreases over time, so that by 10 years after last use, there is not significant association with breast cancer.

He advises that consideration of the risks of OC use should also take into account the benefits. For example, OCs decrease the risk of ovarian and endometrial cancer, he writes, and they have other benefits as well including relief of menstrual disorders, pelvic inflammatory disease, ovarian cysts, and improved bone mineral density.

Cerhan concludes that the study by Kahlenborn’s group highlights the need for more research about recent OC use and for other modifiable factors.

SOURCE: Mayo Clinic Proceedings, October 2006.

RELATED STORIES:
Pill Among Least Effective Birth Control Methods   70 percent of women use contraceptives during their first sexual encounter   Long-term contraception more effective than pills   Gay couples and women over 40 to get free IVF treatment on NHS   Health secretary urges contraception compromise   Contraceptive ring, patch carry blood clot risks   Reminder Stamp Boosts HPV Vaccination   Study adds to evidence on clot risks of non-oral contraceptives   HPV vaccine completion rate among girls is poor, getting worse   Some ob-gyns cite religious conflicts over care   After IVF, some couples get pregnant without help   Web Tool Offers Map to Menopause   Early Menopause Could Also Mean Early Death   Does soy help cool hot flashes after all?   Caffeine not tied to worsening urinary incontinence

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]